Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

Protein Kinase CK2, a Potential Therapeutic Target in Carcinoma Management

Lian H, Su M, Zhu Y, Zhou Y, Soomro SH, Fu H.

Asian Pac J Cancer Prev. 2019 Jan 25;20(1):23-32. Review.

2.

CK2 inhibitor CX-4945 destabilizes NOTCH1 and synergizes with JQ1 against human T-acute lymphoblastic leukemic cells.

Lian H, Li D, Zhou Y, Landesman-Bollag E, Zhang G, Anderson NM, Tang KC, Roderick JE, Kelliher MA, Seldin DC, Fu H, Feng H.

Haematologica. 2017 Jan;102(1):e17-e21. doi: 10.3324/haematol.2016.154013. Epub 2016 Oct 6. No abstract available.

3.

HDAC6 promotes cell proliferation and confers resistance to temozolomide in glioblastoma.

Wang Z, Hu P, Tang F, Lian H, Chen X, Zhang Y, He X, Liu W, Xie C.

Cancer Lett. 2016 Aug 28;379(1):134-42. doi: 10.1016/j.canlet.2016.06.001. Epub 2016 Jun 3.

PMID:
27267806
4.

Transcription factor 3 controls cell proliferation and migration in glioblastoma multiforme cell lines.

Li R, Li Y, Hu X, Lian H, Wang L, Fu H.

Biochem Cell Biol. 2016 Jun;94(3):247-55. doi: 10.1139/bcb-2015-0162. Epub 2016 Feb 22.

PMID:
27105323
5.

MiR-129 triggers autophagic flux by regulating a novel Notch-1/ E2F7/Beclin-1 axis to impair the viability of human malignant glioma cells.

Chen X, Zhang Y, Shi Y, Lian H, Tu H, Han S, Yin J, Peng B, Zhou B, He X, Liu W.

Oncotarget. 2016 Feb 23;7(8):9222-35. doi: 10.18632/oncotarget.7003.

6.

MiR-873 acts as a novel sensitizer of glioma cells to cisplatin by targeting Bcl-2.

Chen X, Zhang Y, Shi Y, Lian H, Tu H, Han S, Peng B, Liu W, He X.

Int J Oncol. 2015 Oct;47(4):1603-11. doi: 10.3892/ijo.2015.3143. Epub 2015 Aug 31.

PMID:
26323558
7.

MicroRNA-503 acts as a tumor suppressor in glioblastoma for multiple antitumor effects by targeting IGF-1R.

Zhang Y, Chen X, Lian H, Liu J, Zhou B, Han S, Peng B, Yin J, Liu W, He X.

Oncol Rep. 2014 Mar;31(3):1445-52. doi: 10.3892/or.2013.2951. Epub 2013 Dec 30.

Supplemental Content

Loading ...
Support Center